Found 12 matching trials
Topical BPM31510 3.0% Cream in Patients With Epidermolysis Bullosa PHASE1 This is a single-center study to investigate the effects of a topical cream...
Show More Location
University of Miami Department of Dermatology
Learn More & Join Trial
BP31510 (Ubidecarenone,USP) Nanosuspension for Intravenous Injection to Patients With Solid Tumors PHASE1 This is a Phase 1a/b multicenter, open-label, non-randomized, dose-escalati...
Show More Location
Palo Alto Medical Foundation
Learn More & Join Trial
A Safety Study of Orally Administered BPM31510 in Healthy Subjects PHASE1 This is an open-label, Phase I study of the bioavailability and safety of B...
Show More Learn More & Join Trial
BPM31510 in Treating Patients With Recurrent High-Grade Glioma Previously Treated With Bevacizumab PHASE1 This phase I trial studies the side effects and best dose of ubidecarenone ...
Show More Location
Stanford University, School of Medicine
Learn More & Join Trial
A Safety Study of Orally Administered BPM31510 in Healthy Subjects PHASE1 This is an open-label, Phase I study of the bioavailability and safety of B...
Show More Learn More & Join Trial
Dose-Ranging Safety and Efficacy Study of Topical Creams Containing API 31510 for the Treatment of in Situ Cutaneous Squamous Cell Carcinoma PHASE2 The purpose of this study is to determine the safety and tolerability of ph...
Show More Location
Multiple Locations
Learn More & Join Trial
Impact of Orally Administered BPM31510 on Mitochondrial Energetics in Older Adults With Sarcopenia EARLY_PHASE1 This study is being done to gather data on whether oral supplementation of ...
Show More Location
AdventHealth Translational Research Institute
Learn More & Join Trial
Assessment of a Large US EHR Database as Meeting FDA Fit-for-Purpose Requirements to Provide External Controls for Study BPM31510 in Participants With Glioblastoma N/A Glioblastoma is a rare, aggressive brain tumor that leads to death within 2...
Show More Status
Active Not Recruiting
Learn More & Join Trial
A Study of BPM31510 With Vitamin K1 in Subjects With Newly Diagnosed Glioblastoma (GB) PHASE2 This is a single-arm, non-randomized, open-label Phase 2 therapeutic study ...
Show More Status
Active Not Recruiting
Location
Cedars-Sinai Medical Center
Learn More & Join Trial
Dose-Ranging Clinical Trial of Topical Creams Containing API 31510 for the Treatment of Superficial Basal Cell Carcinoma PHASE1 The purpose of this study is to determine the safety and tolerability of ph...
Show More Location
Burke Pharmaceuticals
Learn More & Join Trial